UF Health’s Precision Medicine Program is ushering in a new era of genetic medicine, with the introduction of a new name, leadership team and preemptive pharmacogenetics testing.
A pair of Orlando pharmacy students also placed in the top 10 of the Clinical Skills Challenge at ASHP Midyear.
Cooper-DeHoff's study was selected as a Late Breaking Clinical Trial presentation.
The award was presented to Dr. Cooper-DeHoff in recognition of her substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy.
Rhonda Cooper-DeHoff, Pharm.D., M.S., has received the American College of Cardiology’s 2015 Distinguished Associate Award — the first time this award has been given to a pharmacist. Cooper-DeHoff is an associate professor in the department of pharmacotherapy and translational research in the University of Florida College of…
For patients with diabetes and heart disease, less isn’t always more — at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high — or too low, according to Rhonda Cooper-DeHoff, Pharm.D., an associate professor of pharmacy and medicine at UF. She reported her findings in March at the American College of Cardiology’s 59th annual scientific session in Atlanta. She recommends raising the systolic bar above 120 for blood pressure in patients with diabetes and coronary artery disease, saying that levels between 130 and 140 appear to be the most healthful.
